CHMP erkendte, at der var et problem med underindberetning, men fandt ikke, at der var identificeret nogle tegn, som tydede på en forøget risiko for brystkræft.
The CHMP acknowledged the issue of underreporting but did not consider that any signals indicating an increased risk of breast cancer have been identified.